From August 1-5, 2014, Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., led a two-and-a-half day training in Vancouver, BC, for the newly added co-investigators in our upcoming Canadian study of MDMA-assisted psychotherapy for PTSD, Donna Dryer, M.D., and Richard Yensen, Ph.D. Also participating in the training were Phil Wolfson, M.D., Julane Andries, Cody Swift, Linnae Ponte, and Shannon Petitt who will each be co-conducting experimental sessions in our upcoming study of MDMA-assisted psychotherapy for anxiety associated with advanced-stage illness. On July 22, 2014, MAPS Director of Clinical Research Amy Emerson and Clinical Research Scientist Berra Yazar-Klosinski, Ph.D., conducted the Canadian PTSD study initiation visit via remote teleconference to prepare study staff and trial documentation to begin screening and enrolling subjects. MAPS is sponsoring this study in association with MAPS Canada, the first and only Canadian organization dedicated to psychedelic research and education, now able to receive tax-deductible contributions in Canada.
